Literature DB >> 20183175

Annotations on the use of the Mexican norms for the WAIS-III.

Pedro Sanchez Escobedo1, Liz Hollingworth.   

Abstract

This article provides crucial information to judge the appropriateness of the Mexican version of the Wechsler Adult Intelligence Scale-Third Edition and recognizes some limitations in both the process of its adaptation to the Mexican population and the norm development process. This is an effort to contribute to the debate initiated by Suen and Greenspan (2008), who argued in court against the use of Mexican norms in a death penalty case, which depended upon establishing the diagnosis of mental retardation. As a part of the defense team, these scholars argued a number of points against the use of the Mexican norms. With input from the lead researcher on the Mexican standardization process, some of the criticisms are addressed, and further information about the norm development process for this test in Mexico is provided in an attempt to be critical about the strengths and weaknesses of the use of existing Mexican norms. Finally, we argue that results from a single test must not be used to make life and death decisions and that test development is a continuous process influenced by culture, language, and indeed by norm-developing procedures and debates.

Entities:  

Mesh:

Year:  2009        PMID: 20183175     DOI: 10.1080/09084280903098851

Source DB:  PubMed          Journal:  Appl Neuropsychol        ISSN: 0908-4282


  2 in total

1.  Cardiovascular health and cognitive function among Mexican older adults: cross-sectional results from the WHO Study on Global Ageing and Adult Health.

Authors:  Jaime Perales; Ladson Hinton; Jeffrey Burns; Eric D Vidoni
Journal:  Int Psychogeriatr       Date:  2018-04-18       Impact factor: 3.878

2.  Norm comparisons of the Spanish-language and English-language WAIS-III: Implications for clinical assessment and test adaptation.

Authors:  Cynthia M Funes; Juventino Hernandez Rodriguez; Steven Regeser Lopez
Journal:  Psychol Assess       Date:  2016-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.